Reply to M. Buyse et al

Journal of Clinical Oncology

Volumn 29, Issue 35, 2011, Pages 4720-4721

  Korn, Edward L ^a   Freidlin, Boris ^a   Abrams, Jeffrey S ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGING; CANCER SURVIVAL; DISEASE COURSE; HUMAN; LETTER; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PREDICTION; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SAMPLE SIZE;

EID: 83255170995     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2011.38.5195     Document Type: Letter

References (4)

1. Korn EL, Freidlin B, Abrams JS: Overall survival as the outcome for randomized clinical trials with effective subsequent therapies. J Clin Oncol 29:2439-2442, 2011
2. Buyse M, Sargent DJ, Saad ED: Survival is not a good outcome for randomized trials with effective subsequent therapies. J Clin Oncol 29:4719- 4720, 2011
3. Korn EL, Dorey FJ: Applications of crude incidence curves. Stat Med 11:813-829, 1992
4. Freidlin B, Korn EL: Testing treatment effects in the presence of competing risks. Stat Med 24:1703-1712, 2005 (Pubitemid 40754089)